TRAIL enhances thymidine kinase/ganciclovir gene therapy of neuroblastoma cells

被引:0
作者
Christian Beltinger
Simone Fulda
Henning Walczak
Klaus-Michael Debatin
机构
[1] University Children's Hospital,
[2] German Cancer Research Center (DKFZ),undefined
来源
Cancer Gene Therapy | 2002年 / 9卷
关键词
suicide gene therapy; bystander effect; TRAIL; neuroblastoma;
D O I
暂无
中图分类号
学科分类号
摘要
The clinical benefit of suicide gene therapy of tumors has been marginal, mostly due to the low gene transfer efficiency in vivo. The death-inducing ligand, TRAIL, effectively kills many tumor cell types, while sparing most normal tissues. We hypothesized that TRAIL may enhance HSV thymidine kinase/ganciclovir (TK/GCV) gene therapy of tumor cells by augmenting both target and bystander cell kill. Human SH-EP neuroblastoma cells expressing TK as well as bystander cells were effectively killed by apoptosis, and their clonogenicity was ablated following GCV. Human TRAIL enhanced TK/GCV–induced cell death and decreased clonogenicity of TK-expressing cells and also of bystander cells. Cooperation between TRAIL and TK/GCV depended both on caspase activation and on mitochondrial apoptogenic function because both the broad-spectrum caspase inhibitor zVAD.fmk and overexpression of Bcl-2 decreased enhancement of cell kill by TRAIL. Facilitation of TRAIL signalling by up-regulation of TRAIL receptors did not contribute to enhancement because cell surface expression of the agonistic TRAIL receptors 1 and 2 was not increased by TK/GCV. In conclusion, the concerted activation of caspases and the mitochondrial amplification of caspase activation by TK/GCV may explain the cooperative effect of TK/GCV and TRAIL on the kill of neuroblastoma cells. Because combined treatment also augmented the bystander cell kill, the addition of TRAIL may increase the efficacy of TK/GCV gene therapy of neuroblastoma.
引用
收藏
页码:372 / 381
页数:9
相关论文
共 50 条
[11]   Retinoids augment the bystander effect in vitro and in vivo in herpes simplex virus thymidine kinase ganciclovir-mediated gene therapy [J].
Park, JY ;
Elshami, AA ;
Amin, K ;
Rizk, N ;
Kaiser, LR ;
Albelda, SM .
GENE THERAPY, 1997, 4 (09) :909-917
[12]   Inhibition of the NF-κB pathway enhances TRAIL-mediated apoptosis in neuroblastoma cells [J].
Bahri Karacay ;
Salih Sanlioglu ;
Thomas S Griffith ;
Anthony Sandler ;
Daniel J Bonthius .
Cancer Gene Therapy, 2004, 11 :681-690
[13]   Inhibition of the NF-κB pathway enhances TRAIL-mediated apoptosis in neuroblastoma cells [J].
Karacay, B ;
Sanlioglu, S ;
Griffith, TS ;
Sandler, A ;
Bonthius, DJ .
CANCER GENE THERAPY, 2004, 11 (10) :681-690
[14]   Retinoids augment the bystander effect in vitro and in vivo in herpes simplex virus thymidine kinase/ganciclovir-mediated gene therapy [J].
JY Park ;
AA Elshami ;
K Amin ;
N Rizk ;
LR Kaiser ;
SM Albelda .
Gene Therapy, 1997, 4 :909-917
[15]   Photochemically enhanced gene transfection increases the cytotoxicity of the herpes simplex virus thymidine kinase gene combined with ganciclovir [J].
Lina Prasmickaite ;
Anders Høgset ;
Vibeke Murberg Olsen ;
Olav Kaalhus ;
Svein-Ole Mikalsen ;
Kristian Berg .
Cancer Gene Therapy, 2004, 11 :514-523
[16]   Photochemically enhanced gene transfection increases the cytotoxicity of the herpes simplex virus thymidine kinase gene combined with ganciclovir [J].
Prasmickaite, L ;
Hogset, A ;
Olsen, VM ;
Kaalhus, O ;
Mikalsen, SO ;
Berg, K .
CANCER GENE THERAPY, 2004, 11 (07) :514-523
[17]   Long-term connexin-mediated bystander effect in highly tumorigenic human cells in vivo in herpes simplex virus thymidine kinase/ganciclovir gene therapy [J].
A Duflot-Dancer ;
C Piccoli ;
A Rolland ;
H Yamasaki ;
M Mesnil .
Gene Therapy, 1998, 5 :1372-1378
[18]   Long-term connexin-mediated bystander effect in highly tumorigenic human cells in vivo in herpes simplex virus thymidine kinase ganciclovir gene therapy [J].
Duflot-Dancer, A ;
Piccoli, C ;
Rolland, A ;
Yamasaki, H ;
Mesnil, M .
GENE THERAPY, 1998, 5 (10) :1372-1378
[19]   Potent bystander effect in suicide gene therapy using neural stem cells transduced with herpes simplex virus thymidine kinase gene [J].
Li, SY ;
Tokuyama, T ;
Yamamoto, J ;
Koide, M ;
Yokota, N ;
Namba, H .
ONCOLOGY, 2005, 69 (06) :503-508
[20]   Treatment of rat experimental brain tumors by herpes simplex virus thymidine kinase gene-transduced allogeneic tumor cells and ganciclovir [J].
Hiroki Namba ;
Masatoshi Tagawa ;
Tadashi Miyagawa ;
Yasuo Iwadate ;
Shigeru Sakiyama .
Cancer Gene Therapy, 2000, 7 :947-953